BPC-157

BPC-157 (10mg) — Research Peptide

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide with one of the most extensive preclinical research bases of any peptide currently available for laboratory investigation. This 10mg vial format provides researchers with higher-dose flexibility for in vitro studies, dose-response experiments, and longer-duration animal model protocols requiring extended supply.

Mechanism of Action

BPC-157 operates through a multi-pathway mechanism distinguishing it from single-target research compounds. Its most characterised activity involves upregulation of VEGFR2 receptor signalling and downstream Akt-eNOS phosphorylation, producing dose-dependent angiogenic responses in injured tissue. This vascular regeneration pathway underpins its documented effects in tendon, muscle, and mucosal repair models.

Independent of its vascular effects, BPC-157 modulates nitric oxide synthase activity and has demonstrated the ability to counteract the disruption of dopaminergic and serotonergic neurotransmission pathways in rodent models — properties that have generated interest in neurological research applications. It also exhibits direct cytoprotective effects at the gastric mucosal level, acting on both the luminal epithelium and the enteric nervous system.

Research Applications

The 10mg format is particularly suited to:

• Dose-response studies requiring higher concentration ranges
• Extended in vivo protocols (≥8 week animal model studies)
• Multiple simultaneous experimental arms from a single batch
• In vitro cell culture work requiring larger volume reconstitution

Product Specifications

• Peptide: BPC-157 (Body Protection Compound-157)
• Dose: 10mg per vial
• Format: Lyophilised powder, bulk box of 10 vials
• Purity: ≥98% verified by Janoshik third-party HPLC analysis
• Testing: Purity, sterility, endotoxin, heavy metals — Janoshik COA available
• Storage: -20°C lyophilised. Stable 24 months.

For laboratory research use only. Not for human therapeutic use.